Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: Tumour progression or radionecrosis?

Clinical Neurology and Neurosurgery

Volumn 111, Issue 4, 2009, Pages 331-334

  Peca, C ^a   Pacelli, R ^a   Elefante, A ^a   Del Basso De Caro, M L ^a   Vergara, P ^a   Mariniello, G ^a   Giamundo, A ^a   Maiuri, F ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Glioblastoma; Radionecrosis; Recurrence; Temozolomide

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; ATAXIA; BRAIN RADIATION; BRAIN TUMOR; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL PROTOCOL; CONFUSION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; MALE; MEDICAL RECORD REVIEW; MENTAL DETERIORATION; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTCOME ASSESSMENT; PREVALENCE; RADIATION NECROSIS; RADIOSENSITIZATION; REOPERATION; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; ATAXIA; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CONFUSION; DACARBAZINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NECROSIS; NEOPLASM RECURRENCE, LOCAL; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY, ADJUVANT; REOPERATION; TREATMENT OUTCOME;

EID: 63449141069     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.11.003     Document Type: Article

References (21)

1. Watne K., Hager B., Heier M., and Hirschberg H. Reversible oedema and necrosis after irradiation of the brain. Diagnostic procedures and clinical manifestations. Acta Oncol 29 (1990) 891-895
2. Crossen J.R., Garwood D., Glatstein E., and Neuwelt E.A. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12 (1994) 627-642
3. Sheline G.E., Wara W.M., and Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6 (1980) 1215-1228
4. Al-Mefty O., Kersh J.E., Routh A., and Smith R.R. The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 73 (1990) 502-512
5. Rottenberg D. Acute and chronic effects of radiation therapy on the nervous system. In: Rottenberg D. (Ed). Neurological Complications of Cancer Treatment (1991), Butterworth-Heineman, Boston pp. 3-18
6. Stupp R., Dietrich P.Y., Ostermann Kraljevic S., Pica A., Maillard I., Maeder P., et al. Promising survival for patients with newly diagnosed glioblastoma multiform treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 20 (2002) 1375-1382
7. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
8. DeAngelis L.M. Brain tumors. N Engl J Med 344 (2001) 114-123
9. de Wit M.C., de Bruin H.G., Eijkenboom W., Sillevis Smitt P.A., and van den Bent M.J. Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology 63 (2004) 535-537
10. Chamberlain M.C. Treatment options for glioblastoma. Neurosurg Focus 20 (2006) E2
11. Esteve F., Rubin C., Grand S., Kolodie H., and Le Bas J.F. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. Int J Radiat Oncol Biol Phys 40 (1998) 279-286
12. Nelson S.J., Graves E., Pirzkall A., Li X., Antiniw Chan A., Vigneron D.B., et al. In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imaging 16 (2002) 464-476
13. Kashimura H., Inoue T., Beppu T., Ogasawara K., and Ogawa A. Diffusion tensor imaging for differentiation of recurrent brain tumor and radiation necrosis after radiotherapy-three case reports. Clin Neurol Neurosurg 109 (2007) 106-110
14. Cross N.E., and Glantz M.J. Neurologic complications of radiation therapy. Neurol Clin 21 (2003) 249-277
15. Wedge S.R., Porteous J.K., Glaser M.G., Marcus K., and Newlands E.S. In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs 8 (1997) 92-97
16. van Rijn J., Heimans J.J., van den Berg J., van der Valk P., and Slotman B.J. Survival of human glioma cells treated with various combination of temozolomide and X-rays. Int J Radiat Oncol Biol Phys 47 (2000) 779-784
17. Hirose Y., Berger M.S., and Pieper R.O. p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer Res 61 (2001) 1957-1963
18. Hegi M.E., Diserens A.C., Godard S., Dietrich P.Y., Regli L., Ostermann S., et al. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 10 (2004) 1871-1874
19. Antonadou D., Paraskevaidis M., Sarris G., Coliarakis N., Economou I., Karageorgis P., et al. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 20 (2002) 3644-3650
20. Antonadou D. Temozolomide enhances radiation treatment efficacy in brain metastases: a randomized phase II study. 92th Annual Meeting of the American Association for Cancer Research. New Orleans (2001)
21. Verger E., Gil M., Yaya R., Vinolas N., Villa S., Pujol T., et al. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. Int J Radiat Oncol Biol Phys 61 (2005) 185-191